This concept also applies for the treatment of obesity. She added that the root cause of obesity is complex and heterogeneous
Rita Kapoor, MD , believe in providing safe, effective, and personalized care
doi: 10.1186/s12933-017-0621-8 20 PatelDKStrongJ
Worth mentioning is that the degree of reduced food intake between efocipegtrutide and liraglutide (A GLP1R agonist) treated mice did not differ [35] , demonstrating that the enhanced weight decrease was occurring through enhanced energy expenditure
The Lancet 403(10437):16351648 Kosiborod MN, Abildstrm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity